4-(Chloromethyl)-5-methyl-2-phenyloxazole, 95.0%, 250mg

N-(4-Hydroxy-3-methoxybenzyl)-8-methylnonanamide, 95.0%, 250mg

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-(dimethylamino)cyclohexyl]urea, 97%, 100mg

2-(3-Methoxy-5-(methylthio)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 100mg

3-Iodo-2-(pyrrolidin-1-yl)pyridine, 98%, 1g

3-Nitro-1,2,4-triazole [Coupling Agent]>98.0%(HPLC)(T)1g

Feuille de molybdène 99,95% 0,1 x 100 x 100 mm 1 pièce

2-methyl-1-[(oxiran-2-yl)methyl]piperidine, 95.0%, 2g

(R)-2-Amino-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid, 95.0%, 25g

Flacon de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe, pièce de raccordement KF, DN 100, 2000 ml, 130 mm, 1 pièce

Methyl 2-amino-5-cyanobenzoate, 95.0%, 5g

4-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid, 95.0%, 1g

(2R)-2-(3-BROMOPHENYL)PYRROLIDINE, 95.0%, 100mg